Skip to main content
Clinical Trials/NCT02698020
NCT02698020CompletedNot Applicable

Oxygen Delivery During General Anesthesia in Newborn Infants: An Open Randomized Controlled Trial of Two Levels of Inspired Oxygen.

Uppsala University2 sites in 1 country35 target enrollmentStarted: November 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
35
Locations
2
Primary Endpoint
Transcutaneous and blood-gas pO2

Study Overview

Brief Summary

An open randomized control trial investigating the delivery of two levels of inspired oxygen to newborn infants during general anesthesia.

Detailed Description

Eligible infants are infants of less than 44 weeks postconceptional age and without pulmonary disease or demand for supplemental oxygen or assisted ventilation. Control subjects receive current standard of care (anesthesia induction/pre-oxygenation with 80%, maintenance of anesthesia with 40%, and recovery with 80% inspired oxygen). Intervention subjects are maintained on room air throughout the procedure and supplemental oxygen added only if necessary according to the pre-specified oxygen saturation target. Subjects are monitored according to clinical protocols AND with cerebral oximetry (NIRS), transcutaneous measurement of partial pressure of oxygen (pO2), and blood-gas analyses. Blood and urine samples are collected for later analysis of markers for oxidative stress.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
— to 4 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Newborn less than 44 weeks postconceptional age
  • No pulmonary disease, no oxygen requirement, or assisted ventilation
  • No genetic syndrome

Exclusion Criteria

  • Not provided

Arms & Interventions

Control

No Intervention

High level of supplemental inspired oxygen

Room-air

Experimental

Supplemental oxygen only provided if oxygen saturation below target

Intervention: Room-air (Procedure)

Outcomes

Primary Outcomes

Transcutaneous and blood-gas pO2

Time Frame: 30 min

Area under curve (AUC) and absolute values of pO2

Secondary Outcomes

  • Cerebral Oximetry(30 min)
  • Isoprostane(4 h)
  • Atelectasis(30 min)

Investigators

Sponsor
Uppsala University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials